Researchers say this is the first combination therapy that targets two different cancer survival mechanism: PARP and WNT signaling.

Researchers at UCLA have created an “off-the-shelf" cell-based immunotherapy that can seek out and destroy pancreatic cancer ...

UTEP researchers identify Claudin-4 protein as a target to improve immune response against aggressive ovarian cancer.

Diane Davis thought a diagnosis of advanced ovarian cancer was the answer she had been looking for. For months, she had been sick. Antibiotics were no help. When she went to the emergency room, a CT ...

Jessie J—who spoke with Kate Middleton at the Royal Variety Performance—shared more details about their conversation ...

In a case that underscores the profound complexities of human anatomy and the critical importance of medical vigilance, ...

Pancreatic cancer is among the deadliest forms of cancer, with most patients diagnosed after the disease has already spread ...

In what researchers are calling a ”breakthrough hiding in plain sight,” scientists have redesigned a 40-year-old deworming ...

Most new cell therapies work well on blood cancers but not on solid tumors like pancreatic cancer. Pancreatic tumors are ...

The U.S. Food and Drug Administration has proposed to withdraw a rule that would have ensured certain cosmetics were tested ...